MyHeart

MyHeart is an Integrated Project aiming to develop intelligent systems for the prevention and monitoring of cardiovascular diseases.The project develops smart electronic and textile systems and appropriate services that empower the users to take control of their own health status.

Cardio-vascular diseases (CVD) are the leading cause of death in developed countries. Roughly 45% of all deaths in the EU are due to cardio-vascular diseases. With the ageing population, it is a challenge for Europe to provide its citizens with healthcare at affordable costs.

It is the aim of the MyHeart project to fight CVD by prevention and early diagnosis. A healthy and preventive lifestyle as well as early diagnosis of heart diseases could save millions of life years annually, reduce the morbidity significantly and, simultaneously, improve the quality of life of the European citizen. Prevention offers the opportunity to systematically fight the origin of cardio-vascular diseases as well as to improve the medical outcome after an event. Classical medical institutions offer only intermittent, episodical treatment, while prevention asks for a lifelong continuous change of habits and therefore for a continuous health-care delivery process. With its innovative system-solutions for integrated textiles, sensors and on-body electronics, the MyHeart project significantly contributes to the European excellence in the area of bioengineering and thereby to the Lisbon strategy of the EC.

For further information, please visit:
http://www.hitech-projects.com/euprojects/myheart/

Project co-ordinator:
Philips GmbH Forschungslaboratorien, GE

Partners:

  • Philips Electronics UK Limited
  • Philips International B.V. – NL
  • Philips Innovative Technology Solutions NV – B
  • Medtronic Iberia SA – E
  • Fundacion Vodafone – E
  • Milior – S.P.A. – I
  • Smartex – S.R.L – I
  • Dr.Hein GMBH – D
  • Medgate AG – CH
  • Centre Suisse D’Electronique et de Microtechnique SA – CH
  • Commissariat à l’énergie Atomique – F
  • Eidgenossische Technische Hochschule Zurich – CH
  • Universita degli Studi di Pisa – I
  • Universidad Politecnica de Madrid – E
  • Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas - Asociación – E
  • Consorzio di Bioingegneria e Infomatica Medica – I
  • Politecnico di Milano – I
  • Universita’degli studi di Padova (university of Padova) – I
  • Universita degli studi di Firenze – I
  • Universitaetsklinikum Aachen – D
  • Hospital Clinico San Carlos de Madrid Insalud – E
  • Fondazione Centro San Raffaele del Monte Tabor – I
  • Fondazione Salvatore Maugeri Clinica del Lavoro e della Riabilitazione – I
  • Universidad Politecnica de Valencia – E
  • Facludade de ciencias e technologia da universidade de Coimbra – P
  • Hospital de Unisersidate de Coimbra – P
  • Philips Electronics Nederland b.v. – NL
  • Lineapiu S.P.A. – I
  • W. Zimmermann GmbH & Co. KG – D

Timetable: from 01/04 – to 12/08

Total cost: € 34.733.599

EC funding: € 16.000.000

Instrument: IP

Project Identifier: IST-2002-507816

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...